O'Neill Institute
State Action to Lower Prescription Drug Prices: Navigating Patent PreemptionPrescription Drug Affordability Boards
Issue Metadata
More Prescription Drug Affordability tracked topics
-
Price Gouging Laws
Cases Tracked: 7
-
Product Specific Access Laws
Cases Tracked: 5
-
Orange Book Patent Listings
Cases Tracked: 4
-
Transparency Laws
Cases Tracked: 2
Dive Deeper
O'Neill Institute
Pharmaceutical Industry Seeks to Thwart State Initiatives to Tackle Unaffordability of Prescription DrugsMore Issues
- 340B Program 20 cases
- Affordable Care Act 69 cases 6 Topics
- Anticompetitive Practices 23 cases 1 Topics
- Artificial Intelligence 3 cases
- Consumer Protections 17 cases 1 Topics
- Cost Containment 13 cases
- Equity 49 cases 1 Topics
- ERISA 16 cases
- Federal Health Funding 42 cases 4 Topics
- Medicare Advantage 23 cases
- Medicare Drug Price Negotiation 22 cases
- No Surprises Act 40 cases 4 Topics
- Reproductive Health 46 cases 5 Topics
- Site-Neutral Payments 9 cases
- Transparency 6 cases